CAESAREA, Israel, April 26, 2018 /PRNewswire/ — V-Wave Ltd., an Israel-based company that has developed a proprietary, minimally invasive implanted interatrial shunt device for treating patients with severe symptomatic heart failure (HF), announced today that it has closed a Series C financing of $70 million led by Deerfield Management along with participation from new investors – […]
Financial
Conmed Raises FY18 Financial Guidance – Quick Facts
Conmed Corp. (CNMD) announced the company now forecasts full-year 2018 adjusted diluted net earnings per share in the range of $2.15 to $2.20, compared to the previous range of $2.11 to $2.17. This represents growth over 2017 of approximately 14% to 16%. The company now expects full-year 2018 constant-currency sales […]
Edwards Lifesciences Reports First Quarter Results
IRVINE, Calif., April 24, 2018 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended March 31, 2018. First Quarter and Recent Highlights: Sales were $895 million, or $938 million on an adjusted basis Global THVT sales […]
Boston Scientific Announces Results For First Quarter 2018
MARLBOROUGH, Mass., April 25, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated sales of $2.379 billion during the first quarter ended March 31, 2018. This represents growth of 10.1 percent on a reported basis, 6.2 percent on an operational1 basis and 5.2 percent on an organic2 basis, all compared to the prior year period. The company reported […]
Medicure to Announce Fiscal Year End 2017 Financial Results on April 30, 2018
WINNIPEG, April 24, 2018 /PRNewswire/ – Medicure Inc. (“Medicure”) (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, will release financial results for the year ended December 31, 2017 after market close on Monday, April 30, 2018. Medicure will hold a conference call and webcast regarding the results on Tuesday, May 1, 2018at 7:30 AM Central Time (8:30 AM Eastern Time). […]
BD Board Declares Dividends
FRANKLIN LAKES, N.J., April 23, 2018 /PRNewswire/ — The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.75 per common share, payable on June 29, 2018 to holders of record on June 8, 2018. The indicated annual dividend rate is $3.00 per share. In addition, the Board of Directors has declared […]
Bardy Diagnostics™ Announces Appointment of Alan Levy to Board of Directors
SEATTLE, April 24, 2018 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor (“CAM™”), the world’s only P-wave centric™ ambulatory cardiac monitor and arrhythmia detection device, announced today the appointment of Alan J. Levy, PhD to its Board of […]
BioTelemetry, Inc. to Release First Quarter 2018 Earnings Results on April 25, 2018
MALVERN, Pa., April 19, 2018 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT) will release its first quarter 2018 earnings on Wednesday, April 25 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, April 25, 2018. The broadcast will be available through […]
Teleflex Announces First Quarter 2018 Earnings Conference Call Information
WAYNE, Pa.–(BUSINESS WIRE)–Teleflex Incorporated (NYSE: TFX) announced today that financial results for the first quarter 2018 will be released before market open on Thursday, May 3, 2018. An investor conference call will be held at 8:00 a.m. (ET) on Thursday, May 3, 2018. The call can be accessed through a […]
Ra Medical Systems Appoints Andrew Jackson as Chief Financial Officer
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, manufacturers of laser-based solutions for the treatment of cardiovascular and dermatological diseases, announced today that the Company has appointed Andrew Jackson as its Chief Financial Officer, effective immediately. Mr. Jackson has over 20 years of finance experience in life science and technology companies, including extensive […]
Recent
Instylla’s Embrace® Hydrogel Embolic System Receives FDA Approval for Peripheral Arterial Bleeds
Mineralys Therapeutics Announces Publication of Phase 2 Explore-CKD Trial Results for Lorundrostat in Kidney International
Brainomix AI Imaging Analysis of Phase 3 CHARM Trial Identifies Promising Treatment Signals in Severe Stroke Patients
Popular
- No commented posts yet